AIBS has provided testimony to the House Appropriations Committee calling for $51 billion for the National Institutes of Health (NIH) in fiscal year (FY) 2024.
The testimony contends that the requested funding will “grow and sustain the U.S. bioeconomy and enable NIH to accelerate work on important initiatives at the frontiers of science and medicine.” AIBS also argues that increased support is needed to “advance research on infectious disease emergence and transmission, prevent future pandemics, and fill gaps in our knowledge about the spread and evolution of biological threats.”
AIBS further requested that any additional funding to support the new Advanced Research Projects Agency for Health (ARPA-H) should supplement, not supplant, the $51 billion request for the world’s largest public funder of biomedical research. “The new agency charged with support-ing transformative high-risk, high-reward research must complement, and not interfere with, NIH’s commitment to funding basic research.”
Stay current on the latest science policy news. Subscribe to our bi-weekly AIBS Public Policy Report.